nach oben

Erschienen in:

Open Access 09.06.2020 | COVID-19 | Letter

Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial

verfasst von: Chi Zhang, Jiawen Li, Zhao Wu, He Wang, Chengli Que, Hong Zhao, Guiqiang Wang

Titel: Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial
verfasst von: Chi Zhang
Jiawen Li
Zhao Wu
He Wang
Chengli Que
Hong Zhao
Guiqiang Wang
Publikationsdatum: 09.06.2020
Verlag: BioMed Central
Schlagwort: COVID-19
Erschienen in: Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04399-8